258 related articles for article (PubMed ID: 20565746)
1. Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines.
Nagel S; Venturini L; Marquez VE; Meyer C; Kaufmann M; Scherr M; MacLeod RA; Drexler HG
Mol Cancer; 2010 Jun; 9():151. PubMed ID: 20565746
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
3. HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation.
Bei L; Lu Y; Eklund EA
J Biol Chem; 2005 Apr; 280(13):12359-70. PubMed ID: 15681849
[TBL] [Abstract][Full Text] [Related]
4. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.
Zhou J; Bi C; Cheong LL; Mahara S; Liu SC; Tay KG; Koh TL; Yu Q; Chng WJ
Blood; 2011 Sep; 118(10):2830-9. PubMed ID: 21734239
[TBL] [Abstract][Full Text] [Related]
5. Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML.
Yao J; Fang LC; Yang ZL; Huang H; Li Y; Deng J; Zheng J
Biosci Rep; 2014 Dec; 34(6):e00156. PubMed ID: 25307539
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
[TBL] [Abstract][Full Text] [Related]
7. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CDX4 gene transcription by HoxA9, HoxA10, the Mll-Ell oncogene and Shp2 during leukemogenesis.
Bei L; Shah C; Wang H; Huang W; Platanias LC; Eklund EA
Oncogenesis; 2014 Dec; 3(12):e135. PubMed ID: 25531430
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16.
Ueda K; Yoshimi A; Kagoya Y; Nishikawa S; Marquez VE; Nakagawa M; Kurokawa M
Cancer Sci; 2014 May; 105(5):512-9. PubMed ID: 24612037
[TBL] [Abstract][Full Text] [Related]
11. HoxA10 activates transcription of the gene encoding mitogen-activated protein kinase phosphatase 2 (Mkp2) in myeloid cells.
Wang H; Lu Y; Huang W; Papoutsakis ET; Fuhrken P; Eklund EA
J Biol Chem; 2007 Jun; 282(22):16164-76. PubMed ID: 17430893
[TBL] [Abstract][Full Text] [Related]
12. Forced expression of Id2 in fetal thymic T cell progenitors allows some of their progeny to adopt NK cell fate.
Fujimoto S; Ikawa T; Kina T; Yokota Y
Int Immunol; 2007 Oct; 19(10):1175-82. PubMed ID: 17698981
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development.
Zook EC; Li ZY; Xu Y; de Pooter RF; Verykokakis M; Beaulieu A; Lasorella A; Maienschein-Cline M; Sun JC; Sigvardsson M; Kee BL
Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29703840
[TBL] [Abstract][Full Text] [Related]
14. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
15. HOXA9 is required for survival in human MLL-rearranged acute leukemias.
Faber J; Krivtsov AV; Stubbs MC; Wright R; Davis TN; van den Heuvel-Eibrink M; Zwaan CM; Kung AL; Armstrong SA
Blood; 2009 Mar; 113(11):2375-85. PubMed ID: 19056693
[TBL] [Abstract][Full Text] [Related]
16. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Whelan JT; Ludwig DL; Bertrand FE
Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
[TBL] [Abstract][Full Text] [Related]
17. HoxA10 protein regulates transcription of gene encoding fibroblast growth factor 2 (FGF2) in myeloid cells.
Shah CA; Bei L; Wang H; Platanias LC; Eklund EA
J Biol Chem; 2012 May; 287(22):18230-48. PubMed ID: 22493287
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2016 Jul; 7(29):45398-45413. PubMed ID: 27322685
[TBL] [Abstract][Full Text] [Related]
19. Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma.
Nagel S; Pommerenke C; Meyer C; MacLeod RAF; Drexler HG
PLoS One; 2021; 16(2):e0246603. PubMed ID: 33539429
[TBL] [Abstract][Full Text] [Related]
20. Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells.
Ferrell CM; Dorsam ST; Ohta H; Humphries RK; Derynck MK; Haqq C; Largman C; Lawrence HJ
Stem Cells; 2005 May; 23(5):644-55. PubMed ID: 15849172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
